Lightcalls.com
 

permit THIS "FAIRY GODMOTHER" OF HE...

permit THIS "FAIRY GODMOTHER" OF HERBS CARRY YOU in consequence of THE REST OF THE WINTER

the snow is falling outside and raw winds are blowing. But inside, co-workers are coughing while seminarys and day-care centers look like holiday taverns for every cold and flu bug in the neighborhood. It's midwinter, and getting end the rest of the season without getting sick is forward everyone's mind.

To do that, your immune plan has to be strong. You probably already know the basics

EAT a diet rich in in good condition veggies, whole grains, legumes and fruit

DRINK apportionments of water, preferably filtered

acquire REGULAR EXERCISE, if possible in the great outdoors

be still WELL, and, in winter, a little more than usual -- a minimum of 7 to 9 hours by means of night

Most the public also need a good multiple vitamin, and extra vitamin C beta carotene, D and the mineral zinc. Your doctor can number you how much of each of these is right for you.



introducing echinacea

It's important to know about the herb echinacea, for if eternally the germ-wary had a fairy godmother, echinacea is she. Known also as the "purple coneflower," echinacea is native to North America, particularly Kansas, Missouri and Nebraska, however it can be found from the hard Mountains to the East Coast, and southern into Texas.

Native American tribes used echinacea many times and for a wide variety of conditions. Archeologists have base evidence of echinacea among the remains of Native American sites dating back to the 1600 Indians chewed echinacea origin to treat symptoms like cough and sore throat and they included the tea in sweats and steams to treat lower respiratory tract infections; they on a level used the plant in the treatment of gonorrhea.

It was from the American natives that the Eclectic Physicians of the late 19th and early 20th centuries (a national association of doctors using many healing practices) learned of echinaeea's healing powers. The herb was added to the Eclectic Materia Medica in 1887 and, through 1921, was the most popular plant medicine used through Eclectic physicians in treating all manner of conditions.

Dr Harvey Wickes Felter professor of Materia Medica and Therapeutics, and of the History of Medicine in the Eclectic Medical body of Cincinnati, Ohio described echinacea as possessing "varied and remarkable therapeutic forces." According to Eclectic thesiss of the period, echinacea was commended for over 50 listed illnesses, ranging from abscesses and appendicitis between the sides of urethral infection, vulvitis, wasp stings and wounds

Today we have effective mainstream treatments for many of the conditions for which the Eclectics prescribed echinacea. However, when it draw nears to the common cold, present medicine has not yet be able to find us a cure

Nor has fresh medicine created any drug that rivals echinacea in sum of two units ways: the plant's ability to shorten the course of an upper respiratory tract infection and the plant's popularity with the general public.

what's in it?

There are nine species of echinacea, although three of these are the in the greatest degree popularly used and referenced in the one and the other folk and clinical medicine. These are Echinacea angustifolia, Echinacea pallida, and Echinacea purpurea. Echinacea draw nears from the Greek word echinos, meaning sea urchin. A careful await at an echinacea flower in well stocked [i]or[/i] provided bloom will reveal the source of the name: the dark purple cone of the flower does counterfeit a sea urchin.

Scientists are not nevertheless sure which chemical constituents of echinacea are actually responsible for its healing properties. What we do know is that the plant's chemistry is complexus Echinacea extracts contain many settles including flavonoids (color components), essential oils and polysaccharides (plant sugars). It is generally believed that polysaccharides and other mixs are most actively involved ill echinacea's immune-enhancing work.

what it does

A multitude of studies convoyed both through test tubes and forward animals over the past 30 years have examined the effectiveness of echinacea.

Twelve clinical studies, published between 1961 and 1997 conclud that echinacea was useful in treating the often met with cold. Five studies published between 1997 and 2000 revealed different results; sum of two units showed that echinacea did not treat or obviate upper respiratory tract infections, while three base that echinacea diminished the duration, frequent occurrence and severity of common icy symptoms.

Based forward this, the medical consensus appears to be that echinacea may well be highly effective in treating the customary cold. Even skeptics agree that the plant is generally considered safe and patients should not be discouraged from using it to treat their cutting symptoms.

Another sophisticated debate continues forward short-term vs. long-term use of echinacea. The general consensus, supported by way of the German version of our FDA, Commission E is that echinacea should alone be used for a short time, and should be avoided in cases of autoimmune diseases (like multiple sclerosis), a weakened immune scheme (such as in AIDS, cancer or plain asthma), and in pregnancy.



Other Articles
 -Morphotek will collaborat...
 -Eksigent Technologies nam...
 -The benefits of outsourci...
 -Sartorius Corporation ...
 -In our previous column, w...
 -Efoora appointed Michael ...
 -Affymax appointed Anne-Ma...
 -Traditionally, continuous...
 -New Brunswick Scientific ...
 -The German-American firm ...
 -Don G. Burstyn, formerly ...
 -American patients are mor...
 -Summary Prior to va...
 -BioPharm Editorial Adviso...
 -Australia agreed to spend...
 -The Biotechnology Industr...
 -Ambion, The RNA Company i...
 -Therapies based on living...
 -A recent survey found tha...
 -ViroLogic will acquire Ac...
 -Cardinal Health named Joh...
 -One of the greatest chall...
 -As the president of a sma...
 -Sweden-based Biovitrum wi...
 -Nanogen appointed David L...
 -The Experion Process Know...
 -Although biomedical resea...
 -The Supreme Court of Cana...
 -Netherlands-based DSM Bio...
 -David A. Smoller joined S...
 -A few months ago, I wrote...
 -Panacos Pharmaceuticals w...
 -Karen K. Vaccaro will res...
 -Acceleron Pharma appointe...
 -Two quarterly meetings of...
 -Illinois-based Abbot Labo...
 -FKI Logistics announced t...
 -The following corrections...
 -It its widest definition,...
 -UK-based Xcellsyz will li...
 -Andrew P. Aromando joined...
 -Invitrogen's comprehensiv...
 -Last month, we described ...
 -The Swiss life sciences c...
 -Protein Design Labs (PDL)...
 -Model It HNMR, the newest...
 -Tech transfer, like chang...
 -QLT and Atrix Laboratorie...
 -Dendreon announced Christ...
 -Baxter Pharmaceutical Sol...
 -The biopharmaceutical ind...
 -GlaxoSmithKline announced...
 -Montreal-based Caprion Ph...
 -Xenova Group recently ann...
 -Cole-Parmer's new 192-pag...
 -Over the last decade ther...
 -Benchmark your facility p...
 -As biotechnology organiza...
 -Frederick D. Sancillo, fo...
 -Insmed acquired a recombi...
 -Baxter Pharmaceutical Sol...
 -Model It HNMR, the newest...
 -DA's regulation 21 CFR Pa...
 -Robert P. Ryan joined Ath...
 -A new report from Busines...
 -Biotest offers a complete...
 -Swagelok offers a brochur...
 -Partnering is a global ph...
 -Human Genome Sciences CEO...
 -Shorten the process devel...
 -The licensure of biotechn...
 -Rodger Currie joined Amge...
 -The GEA Filtration Model ...
 -A multi-channel chemistry...
 -From June 6-9, San Franci...
 -Skanska USA Building Inc....
 -New Brunswick Scientific'...
 -AVI BioPharma appointed P...
 -Ambion, The RNA Company, ...
 -"If you want to be a...
 -Xcellerex appointed Susan...
 -Researchers identified th...
 -Cool Spring Business Park...
 -In October 2003, Shenzhen...
 -Laureate Pharma appointed...
 -After a 6-5 vote by Calif...
 -QSourcing, a service of Q...
 -The recent discovery of &...
 -Affymax added Douglas L. ...
 -USDA recently approved tw...
 -BioPharm International is...
 -Serologicals has released...
 -This document by Shenzhen...
 -Robert Bronstein joined A...
 -Gloucester Gains Fujisawa...
 -With more than 30 years o...
 -Pall's SUPRAdisc II depth...
 -In today's competitive ma...
 -Protein Design Labs repor...
 -Charles A. Rice will repl...
 -AstraZeneca's Faslodex (f...
.
© 2006 Lightcalls.com All rights reserved.